Skip to content

MATHI MEDICAL

Active
Private limited companyfounded 2024active for 2 yearsChaussée de Louvain 608B, 1380 Lasne, BelgiumKBO/BCE: BE 1005.886.238
Summary

MATHI MEDICAL has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €52,105 and a net result of €86,930. Its solvency ranks better than 28% of 13,511 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€418,269total assets 2025
Equity
€52,105
Profit
€86,930
Turnover not published (micro format)
Financial health
70 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.7%
Structure
Accounts filed 3 days late0 of 1 deed read
Why 70raises riskFounded in 2024Equity €52,105 (12.5% of total assets)lowers riskSize: total assets €418,269Figures for financial year 2025 (filed 03-08-2026)Show the evidence

Checked score

Score 2025
70 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 61% of its sector peers (NACE 46, micro)
Financial strength · tick = 2024
Average
Solvency 37+28
equity 12.5% of total assets
Liquidity 38-23
short-term debt 55.5% · cash 13.5%
Profitability 93+93
return on assets 20.8%
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%

About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,876 companies, NACE 46, micro)
Last 24 months 03-2025: 1.6% 04-2025: 1.7%▲ +0.1 percentage points vs 03-2025 05-2025: 1.7%● unchanged vs 04-2025 06-2025: 2.1%▲ +0.4 percentage points vs 05-2025 07-2025: 2.1%● unchanged vs 06-2025 08-2025: 2.3%▲ +0.2 percentage points vs 07-2025highest value 09-2025: 1.0%▼ -1.3 percentage points vs 08-2025 10-2025: 1.0%● unchanged vs 09-2025 11-2025: 1.0%● unchanged vs 10-2025 12-2025: 1.0%● unchanged vs 11-2025 01-2026: 1.0%● unchanged vs 12-2025 02-2026: 1.1%▲ +0.1 percentage points vs 01-2026 03-2026: 1.1%● unchanged vs 02-2026 04-2026: 1.1%● unchanged vs 03-2026 05-2026: 1.1%● unchanged vs 04-2026 06-2026: 1.1%● unchanged vs 05-2026 07-2026: 1.2%▲ +0.1 percentage points vs 06-2026 08-2026: 1.8%▲ +0.6 percentage points vs 07-2026 09-2026: 0.7%▼ -1.1 percentage points vs 08-2026 10-2026: 0.7%● unchanged vs 09-2026lowest value
Credit of up to €3,500 on 30-day terms is acceptable
Liquidity ample (current ratio 1.8, compared with 1.38 in 2024, above the usual 1.5; short-term debt: 55.5% and cash: 13.5% of total assets), but 87.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 25% on solvency, 36% on liquidity, 86% on profitability and 97% on growth.

The bankruptcy probability was computed on 17-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Founded in 2024
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: total assets €418,269
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €52,105 (12.5% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 03-08-2026)
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-08-2026, 3 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 2 filings
Deviation from the deadline
2025
3 days late
2024
25 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 14 days after the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
18-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Back to profitnet €86,930
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Back in profit in 2025after -€36,825 in 2024 €86,930 View
  • Positive: Among the best 8% on net resultsector median €5,648 · 13,517 companies €86,930 View
  • Total assets 20252 financial years filed €418,269 View

By topic

Financials

Financial year
2025
Total assets
€418,269
Profit
€86,930
Solvency
12.5%
Total assets▲ 89.1%
Net result
20242025
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
12-02-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.